
NVIDIA (NVDA) presents an attractive buying opportunity after pulling back to pre-earnings price levels, backed by strong structural demand and projected 70% revenue growth over the next 12 months.
Telehealth provider Hims & Hers Health (HIMS) is a compelling growth pick breaking out from oversold conditions ahead of an upcoming mobile app redesign and global brand expansion.
Investors seeking crypto momentum should consider MicroStrategy (MSTR) as it targets the $100 price mark, functioning as an amplified vehicle that delivers 1.35x to 1.5x the gains of Bitcoin (BTC).
Within the AI infrastructure and NeoCloud hosting space, accumulate IREN (IREN) for immediate discounted value or Nebius Group (NBIS) for superior operational quality.
Meanwhile, maintain memory chipmakers like Micron Technology (MU) and SK Hynix (SKHY) on watch, but hold off on buying until shares pull back further to establish a safer entry point.

By @BeatTheDenominator